Nectin-4 Targeting ADC Probe for PET Imaging in Solid Tumors
NCT05322512
·
clinicaltrials.gov ↗
NA
Phase
UNKNOWN
Status
20
Enrollment
OTHER
Sponsor class
Conditions
Solid Tumor
Interventions
DRUG:
18F-FDG
Sponsor
Peking University Cancer Hospital & Institute